Precision medicine for hereditary tumors in gynecologic malignancies

Author(s):  
Masayuki Sekine ◽  
Takayuki Enomoto
2021 ◽  
Author(s):  
M Mantiero ◽  
M Ducceschi ◽  
M Bini ◽  
S Lopez ◽  
M Duca ◽  
...  

2010 ◽  
Author(s):  
Megan Lipe ◽  
Deidre Pereira ◽  
Stacy Dodd ◽  
Tim Sannes ◽  
Michelle Bishop ◽  
...  

Author(s):  
Ruha Benjamin

In this response to Terence Keel and John Hartigan’s debate over the social construction of race, I aim to push the discussion beyond the terrain of epistemology and ideology to examine the contested value of racial science in a broader political economy. I build upon Keel’s concern that even science motivated by progressive aims may reproduce racist thinking and Hartigan’s proposition that a critique of racial science cannot rest on the beliefs and intentions of scientists. In examining the value of racial-ethnic classifications in pharmacogenomics and precision medicine, I propose that analysts should attend to the relationship between prophets of racial science (those who produce forecasts about inherent group differences) and profits of racial science (the material-semiotic benefits of such forecasts). Throughout, I draw upon the idiom of speculation—as a narrative, predictive, and financial practice—to explain how the fiction of race is made factual, again and again. 


Sign in / Sign up

Export Citation Format

Share Document